Infectious tolerance and the long-term acceptance of transplanted tissue
- PMID: 16903922
- DOI: 10.1111/j.0105-2896.2006.00406.x
Infectious tolerance and the long-term acceptance of transplanted tissue
Abstract
Short courses of antibody treatment aimed at blocking the coreceptors CD4 and CD8 and/or costimulatory molecules such as CD40L are able to bring about long-term acceptance and tolerance of allogeneic transplants. This tolerant state is operational, in that potential effector cells remain but are tightly regulated through the induction of antigen-specific CD4+ regulatory T cells (Tregs). CD4+ CD25+ FoxP3+ Tregs appear to play a prominent role, although other categories of Tregs have been documented. Transforming growth factor beta (TGFbeta) has been found to play a major role in the induction of the tolerant state with therapeutic antibodies as well as promoting the induction of FoxP3+ T cells from naïve populations. The observation that Tregs can be found in tolerated grafts has led to the idea that they may interact with the grafted tissue to establish a state of acquired privilege symmetrical with a similar privileged microenvironment around antigen-presenting cells in lymphoid tissues. Dampening of aggressive immune responses by Tregs allows antigen to persist and be presented in an innocuous way to promote tolerance in new cohorts of T cells throughout the life of the tolerated graft. Regulation may operate at many stages of an immune response, even as a censor at the terminal differentiation stages of effector function.
Similar articles
-
Regulation and privilege in transplantation tolerance.J Clin Immunol. 2008 Nov;28(6):716-25. doi: 10.1007/s10875-008-9249-5. Epub 2008 Sep 6. J Clin Immunol. 2008. PMID: 18777090
-
Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.Transplantation. 2008 Nov 27;86(10):1352-60. doi: 10.1097/TP.0b013e31818aa43c. Transplantation. 2008. PMID: 19034003
-
Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.Transpl Immunol. 2013 Dec;29(1-4):51-9. doi: 10.1016/j.trim.2013.10.003. Epub 2013 Oct 16. Transpl Immunol. 2013. PMID: 24139939
-
FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.Transpl Immunol. 2012 Jan;26(1):1-10. doi: 10.1016/j.trim.2011.08.009. Epub 2011 Sep 13. Transpl Immunol. 2012. PMID: 21939765 Review.
-
The effects of antibody treatment on regulatory CD4(+)CD25(+) T cells.Transpl Immunol. 2008 Apr;19(1):37-44. doi: 10.1016/j.trim.2007.12.001. Epub 2007 Dec 28. Transpl Immunol. 2008. PMID: 18346636 Review.
Cited by
-
Translating tolerogenic therapies to the clinic - where do we stand?Front Immunol. 2012 Aug 20;3:254. doi: 10.3389/fimmu.2012.00254. eCollection 2012. Front Immunol. 2012. PMID: 22934094 Free PMC article.
-
T cell Allorecognition Pathways in Solid Organ Transplantation.Front Immunol. 2018 Nov 5;9:2548. doi: 10.3389/fimmu.2018.02548. eCollection 2018. Front Immunol. 2018. PMID: 30455697 Free PMC article. Review.
-
Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.Immunity. 2009 Mar 20;30(3):458-69. doi: 10.1016/j.immuni.2008.12.022. Immunity. 2009. PMID: 19303390 Free PMC article.
-
Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment.Front Immunol. 2014 Aug 28;5:409. doi: 10.3389/fimmu.2014.00409. eCollection 2014. Front Immunol. 2014. PMID: 25221554 Free PMC article. Review.
-
The Pursuit of Regulatory T Cells in the Induction of Transplant Tolerance.Adv Exp Med Biol. 2021;1278:273-287. doi: 10.1007/978-981-15-6407-9_14. Adv Exp Med Biol. 2021. PMID: 33523453
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials